Loading...
Efficacy and Safety of Nivolumab in Patients with Advanced Non-small-cell Lung Cancer and Poor Performance Status
Background: Nivolumab efficacy in patients with non-small-cell lung cancer (NSCLC) and performance status (PS) of 2-4 is unclear. We aimed to compare survival, treatment efficacy, and safety in patients with NSCLC with poor PS who received nivolumab plus best supportive care (BSC) with those in pati...
Na minha lista:
| Udgivet i: | J Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ivyspring International Publisher
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6584408/ https://ncbi.nlm.nih.gov/pubmed/31258716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.31217 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|